+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Theravance Biopharma - logo

Theravance Biopharma is a biopharmaceutical company that develops and commercializes human therapeutics. The company offers VIBATIV (telavancin), a bactericidal, once-daily injectable antibiotic. In addition, it has numerous product candidates, including Revefenacin (TD-4208), Axelopran, Velusetrag, TD-6450 and others. It also focuses on various drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. Founded in 2013, it is based in George Town, the Cayman Islands.

Cyclophosphamide Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cyclophosphamide Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
From
From
From
From
Glycopeptide Antibiotics Global Market Report 2024 - Product Thumbnail Image

Glycopeptide Antibiotics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Antibiotic Resistance Global Market Report 2024 - Product Thumbnail Image

Antibiotic Resistance Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Peptide Antibiotics Global Market Report 2024 - Product Thumbnail Image

Peptide Antibiotics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Cell Wall Synthesis Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cell Wall Synthesis Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
From
Loading Indicator